References
- Alegra CJ, Curt GA: Chemotherapy of neoplastic diseases. In Brunton, L.L. Lazo, J.S., Parker, K.L. (Eds.), Goodman & Gilman’s the Pharmacological Basis of Therapeutics 2006, (pp. 1315–1404). McGraw-Hill, New York
- Monica L, Giancarlo, Elpidio MG, Franca A, Antonia F, Stefania P, Vincenzo T, Marina D: Animal models in studies of cardiotoxicity side effects from antiblastic drugs in patients and occupational exposed workers. BioMed Res Int 2014, 240642. https://doi.org/10.1155/2014/240642
- Orbay H, Tobita M, Mizuno H: Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int 2012, 461718.
- Luger D, Lipinski MJ, Westman PC, Glover DK, Dimastromatteo J, Frias, JC, Epstein SE: Intravenously delivered mesenchymal stem cells: systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy. Circ Res 2017, 120(10):1598-1613.
- Elendu C, Amaechi DC, Elendu TC, Amaechi EC, Elendu ID, Omeludike JC, Omeludike EK, Onubogu NC, Ogelle EC, Meduoye OOM, Oloyede PO, Ezeh CP, Esangbedo IJ, Adigwe AC, Akuma NM, Okafor SU: Essential information about nanotechnology in cardiology. Ann Med Surg (Lond) 2025, 87(2):748-779.
- Orhan Y, Başak Ö, Haydardedeoğlu AE, Gungor, CD: Cardioprotective effects of fetal kidney-derived mesenchymal stem cells on doxorubicin-induced cardiotoxicity in rats. Medycyna Weterynaryjna 2022, 78 (2):79-84.
- Lan H, Xue Q, Liu Y: The emerging therapeutic role of mesenchymal stem cells in anthracycline-induced cardiotoxicity. Cell Tissue Res 2021, 384:1-12
- Gugjoo MB: Mesenchymal Stem cells therapeutic applications in cardiovascular disorders. in therapeutic applications of mesenchymal stem cells in veterinary medicine 2022, p. 213-245. Singapore: Springer Nature Singapore.
- Helal OK, Mansy AE, Aly OM, Salama NA: Histological and immunohistochemical study of the possible therapeutic effect of mesenchymal stem cells, their exosomes and vitamin E on experimentally induced cardio-toxicity in adult male albino rats. Benha J Appl Sci 2020, 23(5):165-175.
- Yavuz O, Dinçel GÇ: Expression of cox-2, hmgb-1 and cd68 in lung tissue in sheep fibrinous bronchopneumonia. Medycyna Weterynaryjna 2020, 76(1):46-52.
- Özgermen B, Yavuz O, Haydardedeoğlu AE: Investigation of the effects of mesenchymal stem cell administration on liver recovery in experimental hepatotoxicity model. J Adv Vetbio Sci Tech 2022, 7(2):185-193.
- Tanwar SS, Dwivedi S, Khan S, Sharma S: Cardiomyopathies and a brief insight into DOX-induced cardiomyopathy. The Egyptian Heart Journal 2025, 77(1). doi:10.1186/s43044-025-00628-0
- Rawat PS, Jaiswal A, Khurana A, Bhatti JS, Navik U: Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed Pharmacother 2021, 139:111708.
- Shivakumar P, Rani MU, Reddy AG, Anjaneyulu Y: A study on the toxic effects of Doxorubicin on the histology of certain organs. Toxicol Int 2012, 19(3):241-244.
- Chen X, Chen Y, Bi Y, Fu N, Shan C, Wang S, Xu J: Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy. Cardiovasc Drugs Ther 2007, 21(5):367-374.
- Kuang Z, Ge Y, Cao L, Wang X, Liu K, Wang J, Zhu X, Wu M, Li J: Precision treatment of anthracycline-ınduced cardiotoxicity: an updated review. Curr Treat Options Oncol 2024, 25(8):1038-1054.
- Abushouk AI, Salem AM, Saad A, Afifi AM, Afify AY, Afify H, Abdel-Daim MM: Mesenchymal stem cell therapy for Doxorubicin-induced cardiomyopathy: potential mechanisms, governing factors, and implications of the heart stem cell debate. Front Pharmacol 2019, 10:635.
- Fox JM, Chamberlain G, Ashton BA, Middleton J: Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 2007, 137(6):491-502.
- Chen SL, Fang WW, Qian J, Ye F, Liu YH, Shan SJ, Zhang JJ, Lin S, Liao LM, Zhao RC: Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chin Med J (Eng) 2004, 117:1443-1448.
- Bolli R, Perin EC, Willerson JT, Yang PC, Traverse JH, Henry TD, Simari RD: Allogeneic mesenchymal cell therapy in anthracycline-induced cardiomyopathy heart failure patients. JACC: Cardio Oncol 2020, 2(4):581-595
- Nagyova M, Slovinska L, Blasko J, Grulova I, Kuricova M, Cigankova V, Cizkova D: A comparative study of PKH67, DiI, and BrdU labeling techniques for tracing rat mesenchymal stem cells. In Vitro Cell Dev Biol Anim 2014, 50(7):656-663.
- Li N, Yang H, Lu L, Duan C, Zhao C, Zhao, H: Comparison of the labeling efficiency of BrdU, DiI and FISH labeling techniques in bone marrow stromal cells. Brain Res 2008, 1215:11-19.
- Yang L, Hu R, Yuan C, Guan L, Mu Y: Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine. Open Life Sci 2023, 18(1):20220620.